
Sign up to save your podcasts
Or


Immad and Raj sit down with Celine Halioua, founder and CEO of Loyal, a pioneering biotech company developing drugs to increase lifespan longevity in dogs. This episode highlights the unique challenges of building a biotech company, from navigating FDA approval processes to explaining longevity science to investors. The conversation also explores alternative funding sources beyond traditional VC, with all three founders sharing war stories about their toughest fundraising experiences. Whether you're interested in biotech, startup fundraising, or the future of longevity research, this conversation offers valuable insights into building innovative companies without relying on the typical Silicon Valley playbook.
Want to join the conversation? Connect with us on Tribe:
https://trbcht.com/invites/WmHNjar5ZN
By Immad Akhund and Rajat Suri4.7
1313 ratings
Immad and Raj sit down with Celine Halioua, founder and CEO of Loyal, a pioneering biotech company developing drugs to increase lifespan longevity in dogs. This episode highlights the unique challenges of building a biotech company, from navigating FDA approval processes to explaining longevity science to investors. The conversation also explores alternative funding sources beyond traditional VC, with all three founders sharing war stories about their toughest fundraising experiences. Whether you're interested in biotech, startup fundraising, or the future of longevity research, this conversation offers valuable insights into building innovative companies without relying on the typical Silicon Valley playbook.
Want to join the conversation? Connect with us on Tribe:
https://trbcht.com/invites/WmHNjar5ZN

1,283 Listeners

530 Listeners

172 Listeners

1,081 Listeners

2,085 Listeners

232 Listeners

9,826 Listeners

192 Listeners

488 Listeners

161 Listeners

259 Listeners

133 Listeners

509 Listeners

22 Listeners

40 Listeners